References
- ESCMID Sore Throat Guideline Group , PelucchiC , GrigoryanL , GaleoneC , EspositoS , HuovinenP . Guideline for the management of acute sore throat . Clin. Microbiol. Infect.18 ( 1 ), 1 – 28 ( 2012 ).
- Farrar JT , PortenoyRK , BerlinJA , KinmanJL , StromBL . Defining the clinically important difference in pain outcome measures . Pain88 ( 3 ), 287 – 294 ( 2000 ).
- Russo M , BlochM , de LoozeF , MorrisC , ShephardA . Flurbiprofen microgranules for relief of sore throat: a randomised, double-blind trial . Br. J. Gen. Pract.63 , e149 – e155 ( 2013 ).
- Schachtel B , AspleyS , ShephardAet al. Onset of action of a lozenge containing flurbiprofen 8.75 mg: a randomized, double-blind, placebo-controlled trial with a new method for measuring onset of analgesic activity . Pain155 ( 2 ), 422 – 428 ( 2014 ).
- Schachtel B , ShephardA , AspleySet al. Demonstration of clinically important relief and the percent change in pain intensity at the time of meaningful relief by flurbiprofen 8.75 mg lozenge . J. Pain16 ( 4 ), S66 ( 2015 ).
- de Looze F , RussoM , BlochMet al. Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: a randomised controlled trial . Eur. J. Gen. Pract.22 ( 2 ), 111 – 118 ( 2016 ).
- Schachtel B , AspleyS , ShephardA , SheaT , SmithG , SchachtelE . Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study . Trials15 , 263 ( 2014 ).
- van Driel ML , De SutterA , DeveugeleMet al. Are sore throat patients who hope for antibiotics actually asking for pain relief? Ann. Fam. Med. 4 ( 6 ), 494 – 499 ( 2006 ).
- Radkova E , BurovaN , BychkovaN , DeVitoR . Efficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection: a randomized, non-inferiority trial in the Russian Federation . J. Pain Res.10 , 1591 – 1600 ( 2017 ).
- Bouroubi A , DonazzoloY , DonathFet al. Pain relief of sore throat with a new anti-inflammatory throat lozenge, ibuprofen 25 mg: a randomised, double-blind, placebo-controlled, international Phase III study . Int. J. Clin. Pract.71 ( 9 ), doi:10.1111/ijcp.12961 ( 2017 ) ( Epub ahead of print ).